Arkansas is asking for a minimum of $1.2 billion in fines for the 250,000 Risperdal prescriptions issued under its medicaid program. Fletch Trammel, lawyer for Arkansas, says that Johnson & Johnson’s subsidiary Janssen lied about side effects of the drug. Defense attorneys say there is no evidence anyone was injured or that the state lost any money. Jury deliberations begin this afternoon.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.